Unlicensed uses for medication in a palliative care unit.

Area of Science:

• Palliative Care Medicine
• Pharmacology
• Oncology

Background:

• Palliative care units manage patients with advanced malignancy, often requiring complex symptom management.
• Established drug licenses may not cover all indications needed for optimal patient care.

Purpose of the Study:

• To assess the frequency and scope of medication use for unlicensed indications within a specialist palliative care unit.
• To compare prescribed medications against licensed indications for patients with advanced malignancy.

Main Methods:

• A prospective study was conducted over four months in a 10-bed specialist palliative care unit.
• Prescriptions for all admitted patients with advanced malignancy were reviewed.
• Prescribing events were compared with official licensed prescribing indications.

Main Results:

• Seventy-six patients were included, with 689 prescriptions issued for 84 different drugs across 34 symptoms.
• Fifteen percent of all prescribing events were for indications not supported by product licenses.
• Unlicensed drug use was common, particularly for managing challenging symptoms.

Conclusions:

• Medications are frequently utilized for unlicensed purposes in palliative care settings.
• This off-label prescribing, while often literature-supported, is crucial for symptom control in advanced malignancy.
• Further research may be warranted to explore the efficacy and safety of these unlicensed uses.